4 results
·
18ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·ONCO/Reveal Dx Lung & Colon Cancer Assay (O/RDx-LCCA)
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·oncoRevealTM CDx
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·ONCO/Reveal Dx Lung & Colon Cancer Assay (O/RDx-LCCA)
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA classification
FDA Class 3
·Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System